Get started
Author

Pawel Mielnik

Observed name: Paweł Mielnik
Institution: Helse Førde
ORCID: 0000-0002-3894-5371
Observed ORCIDs: 0000-0002-3894-5371, 0000-0003-1814-9834
OpenAlex ID: A5135628238
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network
2025 · Lykke M. Ørnbjerg, Marion Pons, et al. · The Journal of Rheumatology · 5
PDF
Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration
2026 · Jette Heberg, Stylianos Georgiadis, et al. · The Journal of Rheumatology
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis
2026 · Zohra Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, et al. · RMD Open
The essence of cause and effect in Roman Ingarden's The Dispute over the Existence of the World
2026 · Paweł Mielnik · Studia Koszalińsko-Kołobrzeskie
PDF
Works count: 4
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type